期刊文献+

血管血栓性疾病的发病机制和防治 被引量:19

Pathogenic mechanism and treatment of vascular thromboenbolism disease
下载PDF
导出
摘要 血管血栓性疾病是多发病、常见病,它严重危害人类健康。其发病机制是血管中血栓形成,引起血栓形成的因素很多,危险因素有基因、环境和生活行为(如吸烟)。动脉血栓形成的基础病变是动脉粥样硬化,血小板黏附聚集在动脉血栓形成中起“扳机”作用,静脉血栓形成的主要因素是淤血和高凝。预防动脉血栓形成主要是降血脂和抗血小板黏附、聚集,而预防静脉血栓形成则抗凝和采取措施减轻淤血。动脉血栓的治疗方案主要是溶血栓和/或经皮冠脉介入术(PC I),静脉血栓的治疗方案主要是抗凝。此外,本文还介绍了微血管血栓的形成机制和防治。 Thromboembolism of vascular is a human common disease. The onset of thrombotic disease is due to thrombosis in vascular which produced from multiple factors including gene, environment and life behavior (eg. smoking). The formation of arteriosclerosis plaque is involved in the basic pathologic change of arterial thrombosis, The platelet adhesive and aggregation is action as a "trigger" in arterial thrombosis. The prevented and therapeutic approaches of the disease are suggested to be lipid-lowering, antiplatelet, thrombolytic drug and percutaneous coronary intervention( PCI), respectively. The mainly pathologic phenotype of venous thrombosis revealed with blood stasis and hypercoagulation. Decrease stasis and anticoagulation can be used as efficient prevented and therapeutic methods for the disease.
作者 李家增
出处 《基础医学与临床》 CSCD 北大核心 2006年第6期561-565,共5页 Basic and Clinical Medicine
关键词 栓塞 血栓形成 抗血小板 抗凝 溶血栓 thromboembolism thrombosis antiplatelet anticoagulation thrombolytic
  • 相关文献

参考文献18

  • 1Rosendaal FR.Venous thrombosis:The role of genes,environment,and behavior[M]// Schechter GP,Bajus JL,McArthur JR,et al.American Society of Hematology Education Program Book,Washington,DC:American Society of Hematology,2005:1-8.
  • 2Ten Wolde M,Kraaijenhagen RA,Schiereck J,et al,Travel and the risk of symptomatic venous thromboembolism[J].Thromb Haemost,2003,89:499-505.
  • 3Goldhaber SZ,Pulmonary embolism[J].Lancet,2004,363:1295-1305.
  • 4Kromsdorf U,Ostermayer S,Billinger K,et al.Incidence and clinical course of thrombus formation in atrial septal defects and patent foramen ovale closure devices in 1000 consecutive patients[J].J Am Coll Cardial,2004,43:302 -309.
  • 5Overell JR,Bone I,Lees KR,Interatrial septal abnormalities and stroke;a meta-analysis of case controlled studies[J].Neurology,2000,55:1172-1179.
  • 6Lee AY,Rickles FR,Julian JA,et al.Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism[J].J Clin Oncol,2005,23:2123 -2129.
  • 7Albers GW,Bates VE,Clark MN,et al.Intravenous tissue-type plasminogen activator for treatment of acute stroke the Standard Treatment with Alteplasee to Reverse Stroke (STARS) study[J].JAMA,2000,283:1145-1150.
  • 8Sherman DG,Atkinson RP,Chippendalt T,et al.Intravenous ancrod for treatment of acute ischemic stroke:the STAT study:a randomized controlled trial,stroke treatment with ancrod trial[J].JAMA,283:2395 -2403.
  • 9Tateishi-Yuyama E,Matsubora H,Murohara T,et al.Therapeutic angiogenesis for patients with limb ischaemia by autologaus transplantation of bone-marrow cells:a pilot study and a randomized controlled trial[J].Lancet,2002,360:427-435.
  • 10Ho HK,Jang JJ,Kaji S.Developmental endothelia; lacus-1 (Del-1) a novel angiogenic protein:ist role in ischemia[J].Circulation,2004,109:1314-1319.

同被引文献133

引证文献19

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部